HEADER TRANSFERASE 07-AUG-19 6Q27 TITLE N-ACETYLMANNOSAMINE KINASE WITH N-ACETYLMANNOSAMINE FROM TITLE 2 STAPHYLOCOCCUS AUREUS COMPND MOL_ID: 1; COMPND 2 MOLECULE: GLUCOKINASE; COMPND 3 CHAIN: A, B, C, D; COMPND 4 SYNONYM: N-ACETYLMANNOSAMINE KINASE,ROK FAMILY PROTEIN; COMPND 5 EC: 2.7.1.2,2.7.1.85; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: STAPHYLOCOCCUS AUREUS; SOURCE 3 ORGANISM_TAXID: 1280; SOURCE 4 GENE: BGLK, EP54_02970, EQ90_08795, NCTC10654_00349, SOURCE 5 NCTC10702_00557, RK64_02145; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS ROK, SUGAR KINASE, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR D.COOMBES,C.R.HORNE,J.S.DAVIES,R.C.J.DOBSON REVDAT 5 13-MAR-24 6Q27 1 HETSYN REVDAT 4 29-JUL-20 6Q27 1 COMPND REMARK HETNAM SITE REVDAT 4 2 1 ATOM REVDAT 3 18-MAR-20 6Q27 1 JRNL REVDAT 2 29-JAN-20 6Q27 1 JRNL REVDAT 1 22-JAN-20 6Q27 0 JRNL AUTH D.COOMBES,J.S.DAVIES,M.C.NEWTON-VESTY,C.R.HORNE,T.G.SETTY, JRNL AUTH 2 R.SUBRAMANIAN,J.W.B.MOIR,R.FRIEMANN,S.PANJIKAR, JRNL AUTH 3 M.D.W.GRIFFIN,R.A.NORTH,R.C.J.DOBSON JRNL TITL THE BASIS FOR NON-CANONICAL ROK FAMILY FUNCTION IN JRNL TITL 2 THEN-ACETYLMANNOSAMINE KINASE FROM THE JRNL TITL 3 PATHOGENSTAPHYLOCOCCUS AUREUS. JRNL REF J.BIOL.CHEM. V. 295 3301 2020 JRNL REFN ESSN 1083-351X JRNL PMID 31949045 JRNL DOI 10.1074/JBC.RA119.010526 REMARK 2 REMARK 2 RESOLUTION. 2.20 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.20 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 44.56 REMARK 3 DATA CUTOFF (SIGMA(F)) : 1.390 REMARK 3 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 3 NUMBER OF REFLECTIONS : 63747 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : NULL REMARK 3 R VALUE (WORKING + TEST SET) : 0.198 REMARK 3 R VALUE (WORKING SET) : 0.194 REMARK 3 FREE R VALUE : 0.232 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 9.950 REMARK 3 FREE R VALUE TEST SET COUNT : 6340 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 8840 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 60 REMARK 3 SOLVENT ATOMS : 89 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 52.14 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): NULL REMARK 3 ESU BASED ON FREE R VALUE (A): NULL REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.300 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 DISTANCE RESTRAINTS. RMS SIGMA REMARK 3 BOND LENGTH (A) : NULL ; NULL REMARK 3 ANGLE DISTANCE (A) : NULL ; NULL REMARK 3 INTRAPLANAR 1-4 DISTANCE (A) : NULL ; NULL REMARK 3 H-BOND OR METAL COORDINATION (A) : NULL ; NULL REMARK 3 REMARK 3 PLANE RESTRAINT (A) : NULL ; NULL REMARK 3 CHIRAL-CENTER RESTRAINT (A**3) : NULL ; NULL REMARK 3 REMARK 3 NON-BONDED CONTACT RESTRAINTS. REMARK 3 SINGLE TORSION (A) : NULL ; NULL REMARK 3 MULTIPLE TORSION (A) : NULL ; NULL REMARK 3 H-BOND (X...Y) (A) : NULL ; NULL REMARK 3 H-BOND (X-H...Y) (A) : NULL ; NULL REMARK 3 REMARK 3 CONFORMATIONAL TORSION ANGLE RESTRAINTS. REMARK 3 SPECIFIED (DEGREES) : NULL ; NULL REMARK 3 PLANAR (DEGREES) : NULL ; NULL REMARK 3 STAGGERED (DEGREES) : NULL ; NULL REMARK 3 TRANSVERSE (DEGREES) : NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6Q27 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 07-AUG-19. REMARK 100 THE DEPOSITION ID IS D_1000243505. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 09-MAR-17 REMARK 200 TEMPERATURE (KELVIN) : 110 REMARK 200 PH : 5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : AUSTRALIAN SYNCHROTRON REMARK 200 BEAMLINE : MX2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.954 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315R REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 124343 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.200 REMARK 200 RESOLUTION RANGE LOW (A) : 44.556 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 200 DATA REDUNDANCY : 2.000 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 4.9000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.20 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.28 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 51.27 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.52 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.2 M L-ARGININE, 0.1 M SODIUM REMARK 280 ACETATE, PH 5.0 IN 8% W/V POLY-GAMMA-GLUTAMIC ACID, VAPOR REMARK 280 DIFFUSION, SITTING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 50.67650 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 4250 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 23290 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -1.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 4270 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 23290 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -2.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 APPLY THE FOLLOWING TO CHAINS: D REMARK 350 BIOMT1 2 1.000000 0.000000 0.000000 0.34877 REMARK 350 BIOMT2 2 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 1.000000 -133.22154 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 20 CG CD CE NZ REMARK 470 GLN A 73 CG CD OE1 NE2 REMARK 470 GLN A 144 CG CD OE1 NE2 REMARK 470 LYS A 263 CG CD CE NZ REMARK 470 LYS B 20 CG CD CE NZ REMARK 470 GLN B 144 CG CD OE1 NE2 REMARK 470 LYS B 263 CG CD CE NZ REMARK 470 LYS C 20 CG CD CE NZ REMARK 470 GLN C 144 CG CD OE1 NE2 REMARK 470 LYS C 263 CG CD CE NZ REMARK 470 LYS D 20 CG CD CE NZ REMARK 470 GLN D 144 CG CD OE1 NE2 REMARK 470 LYS D 263 CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OD2 ASP C 108 O6 BM3 C 301 1.77 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LYS A 36 -72.70 -104.85 REMARK 500 TYR A 102 75.97 -103.32 REMARK 500 SER A 192 -179.91 -174.06 REMARK 500 LYS B 36 -71.97 -104.60 REMARK 500 TYR B 102 77.61 -105.13 REMARK 500 LYS C 36 -70.62 -105.53 REMARK 500 TYR C 102 76.35 -101.76 REMARK 500 LYS D 36 -69.84 -106.73 REMARK 500 TYR D 102 77.40 -103.31 REMARK 500 REMARK 500 REMARK: NULL DBREF1 6Q27 A 2 286 UNP A0A266CX40_STAAU DBREF2 6Q27 A A0A266CX40 2 286 DBREF1 6Q27 B 2 286 UNP A0A266CX40_STAAU DBREF2 6Q27 B A0A266CX40 2 286 DBREF1 6Q27 C 2 286 UNP A0A266CX40_STAAU DBREF2 6Q27 C A0A266CX40 2 286 DBREF1 6Q27 D 2 286 UNP A0A266CX40_STAAU DBREF2 6Q27 D A0A266CX40 2 286 SEQRES 1 A 285 TYR TYR ILE ALA ILE ASP ILE GLY GLY THR GLN ILE LYS SEQRES 2 A 285 SER ALA VAL ILE ASP LYS GLN LEU ASN MET PHE ASP TYR SEQRES 3 A 285 GLN GLN ILE SER THR PRO ASP ASN LYS SER GLU LEU ILE SEQRES 4 A 285 THR ASP LYS VAL TYR GLU ILE VAL THR GLY TYR MET LYS SEQRES 5 A 285 GLN TYR GLN LEU ILE GLN PRO VAL ILE GLY ILE SER SER SEQRES 6 A 285 ALA GLY VAL VAL ASP GLU GLN LYS GLY GLU ILE VAL TYR SEQRES 7 A 285 ALA GLY PRO THR ILE PRO ASN TYR LYS GLY THR ASN PHE SEQRES 8 A 285 LYS ARG LEU LEU LYS SER LEU SER PRO TYR VAL LYS VAL SEQRES 9 A 285 LYS ASN ASP VAL ASN ALA ALA LEU LEU GLY GLU LEU LYS SEQRES 10 A 285 LEU HIS GLN TYR GLN ALA GLU ARG ILE PHE CYS MET THR SEQRES 11 A 285 LEU GLY THR GLY ILE GLY GLY ALA TYR LYS ASN ASN GLN SEQRES 12 A 285 GLY HIS ILE ASP ASN GLY GLU LEU HIS LYS ALA ASN GLU SEQRES 13 A 285 VAL GLY TYR LEU LEU TYR ARG PRO THR GLU ASN THR THR SEQRES 14 A 285 PHE GLU GLN ARG ALA ALA THR SER ALA LEU LYS LYS ARG SEQRES 15 A 285 MET ILE ALA GLY GLY PHE THR ARG SER THR HIS VAL PRO SEQRES 16 A 285 VAL LEU PHE GLU ALA ALA GLU GLU GLY ASP ASP ILE ALA SEQRES 17 A 285 LYS GLN ILE LEU ASN GLU TRP ALA GLU ASP VAL ALA GLU SEQRES 18 A 285 GLY ILE ALA GLN ILE GLN VAL MET TYR ASP PRO GLY LEU SEQRES 19 A 285 ILE LEU ILE GLY GLY GLY ILE SER GLU GLN GLY ASP ASN SEQRES 20 A 285 LEU ILE LYS TYR ILE GLU PRO LYS VAL ALA HIS TYR LEU SEQRES 21 A 285 PRO LYS ASP TYR VAL TYR ALA PRO ILE GLN THR THR LYS SEQRES 22 A 285 SER LYS ASN ASP ALA ALA LEU TYR GLY CYS LEU GLN SEQRES 1 B 285 TYR TYR ILE ALA ILE ASP ILE GLY GLY THR GLN ILE LYS SEQRES 2 B 285 SER ALA VAL ILE ASP LYS GLN LEU ASN MET PHE ASP TYR SEQRES 3 B 285 GLN GLN ILE SER THR PRO ASP ASN LYS SER GLU LEU ILE SEQRES 4 B 285 THR ASP LYS VAL TYR GLU ILE VAL THR GLY TYR MET LYS SEQRES 5 B 285 GLN TYR GLN LEU ILE GLN PRO VAL ILE GLY ILE SER SER SEQRES 6 B 285 ALA GLY VAL VAL ASP GLU GLN LYS GLY GLU ILE VAL TYR SEQRES 7 B 285 ALA GLY PRO THR ILE PRO ASN TYR LYS GLY THR ASN PHE SEQRES 8 B 285 LYS ARG LEU LEU LYS SER LEU SER PRO TYR VAL LYS VAL SEQRES 9 B 285 LYS ASN ASP VAL ASN ALA ALA LEU LEU GLY GLU LEU LYS SEQRES 10 B 285 LEU HIS GLN TYR GLN ALA GLU ARG ILE PHE CYS MET THR SEQRES 11 B 285 LEU GLY THR GLY ILE GLY GLY ALA TYR LYS ASN ASN GLN SEQRES 12 B 285 GLY HIS ILE ASP ASN GLY GLU LEU HIS LYS ALA ASN GLU SEQRES 13 B 285 VAL GLY TYR LEU LEU TYR ARG PRO THR GLU ASN THR THR SEQRES 14 B 285 PHE GLU GLN ARG ALA ALA THR SER ALA LEU LYS LYS ARG SEQRES 15 B 285 MET ILE ALA GLY GLY PHE THR ARG SER THR HIS VAL PRO SEQRES 16 B 285 VAL LEU PHE GLU ALA ALA GLU GLU GLY ASP ASP ILE ALA SEQRES 17 B 285 LYS GLN ILE LEU ASN GLU TRP ALA GLU ASP VAL ALA GLU SEQRES 18 B 285 GLY ILE ALA GLN ILE GLN VAL MET TYR ASP PRO GLY LEU SEQRES 19 B 285 ILE LEU ILE GLY GLY GLY ILE SER GLU GLN GLY ASP ASN SEQRES 20 B 285 LEU ILE LYS TYR ILE GLU PRO LYS VAL ALA HIS TYR LEU SEQRES 21 B 285 PRO LYS ASP TYR VAL TYR ALA PRO ILE GLN THR THR LYS SEQRES 22 B 285 SER LYS ASN ASP ALA ALA LEU TYR GLY CYS LEU GLN SEQRES 1 C 285 TYR TYR ILE ALA ILE ASP ILE GLY GLY THR GLN ILE LYS SEQRES 2 C 285 SER ALA VAL ILE ASP LYS GLN LEU ASN MET PHE ASP TYR SEQRES 3 C 285 GLN GLN ILE SER THR PRO ASP ASN LYS SER GLU LEU ILE SEQRES 4 C 285 THR ASP LYS VAL TYR GLU ILE VAL THR GLY TYR MET LYS SEQRES 5 C 285 GLN TYR GLN LEU ILE GLN PRO VAL ILE GLY ILE SER SER SEQRES 6 C 285 ALA GLY VAL VAL ASP GLU GLN LYS GLY GLU ILE VAL TYR SEQRES 7 C 285 ALA GLY PRO THR ILE PRO ASN TYR LYS GLY THR ASN PHE SEQRES 8 C 285 LYS ARG LEU LEU LYS SER LEU SER PRO TYR VAL LYS VAL SEQRES 9 C 285 LYS ASN ASP VAL ASN ALA ALA LEU LEU GLY GLU LEU LYS SEQRES 10 C 285 LEU HIS GLN TYR GLN ALA GLU ARG ILE PHE CYS MET THR SEQRES 11 C 285 LEU GLY THR GLY ILE GLY GLY ALA TYR LYS ASN ASN GLN SEQRES 12 C 285 GLY HIS ILE ASP ASN GLY GLU LEU HIS LYS ALA ASN GLU SEQRES 13 C 285 VAL GLY TYR LEU LEU TYR ARG PRO THR GLU ASN THR THR SEQRES 14 C 285 PHE GLU GLN ARG ALA ALA THR SER ALA LEU LYS LYS ARG SEQRES 15 C 285 MET ILE ALA GLY GLY PHE THR ARG SER THR HIS VAL PRO SEQRES 16 C 285 VAL LEU PHE GLU ALA ALA GLU GLU GLY ASP ASP ILE ALA SEQRES 17 C 285 LYS GLN ILE LEU ASN GLU TRP ALA GLU ASP VAL ALA GLU SEQRES 18 C 285 GLY ILE ALA GLN ILE GLN VAL MET TYR ASP PRO GLY LEU SEQRES 19 C 285 ILE LEU ILE GLY GLY GLY ILE SER GLU GLN GLY ASP ASN SEQRES 20 C 285 LEU ILE LYS TYR ILE GLU PRO LYS VAL ALA HIS TYR LEU SEQRES 21 C 285 PRO LYS ASP TYR VAL TYR ALA PRO ILE GLN THR THR LYS SEQRES 22 C 285 SER LYS ASN ASP ALA ALA LEU TYR GLY CYS LEU GLN SEQRES 1 D 285 TYR TYR ILE ALA ILE ASP ILE GLY GLY THR GLN ILE LYS SEQRES 2 D 285 SER ALA VAL ILE ASP LYS GLN LEU ASN MET PHE ASP TYR SEQRES 3 D 285 GLN GLN ILE SER THR PRO ASP ASN LYS SER GLU LEU ILE SEQRES 4 D 285 THR ASP LYS VAL TYR GLU ILE VAL THR GLY TYR MET LYS SEQRES 5 D 285 GLN TYR GLN LEU ILE GLN PRO VAL ILE GLY ILE SER SER SEQRES 6 D 285 ALA GLY VAL VAL ASP GLU GLN LYS GLY GLU ILE VAL TYR SEQRES 7 D 285 ALA GLY PRO THR ILE PRO ASN TYR LYS GLY THR ASN PHE SEQRES 8 D 285 LYS ARG LEU LEU LYS SER LEU SER PRO TYR VAL LYS VAL SEQRES 9 D 285 LYS ASN ASP VAL ASN ALA ALA LEU LEU GLY GLU LEU LYS SEQRES 10 D 285 LEU HIS GLN TYR GLN ALA GLU ARG ILE PHE CYS MET THR SEQRES 11 D 285 LEU GLY THR GLY ILE GLY GLY ALA TYR LYS ASN ASN GLN SEQRES 12 D 285 GLY HIS ILE ASP ASN GLY GLU LEU HIS LYS ALA ASN GLU SEQRES 13 D 285 VAL GLY TYR LEU LEU TYR ARG PRO THR GLU ASN THR THR SEQRES 14 D 285 PHE GLU GLN ARG ALA ALA THR SER ALA LEU LYS LYS ARG SEQRES 15 D 285 MET ILE ALA GLY GLY PHE THR ARG SER THR HIS VAL PRO SEQRES 16 D 285 VAL LEU PHE GLU ALA ALA GLU GLU GLY ASP ASP ILE ALA SEQRES 17 D 285 LYS GLN ILE LEU ASN GLU TRP ALA GLU ASP VAL ALA GLU SEQRES 18 D 285 GLY ILE ALA GLN ILE GLN VAL MET TYR ASP PRO GLY LEU SEQRES 19 D 285 ILE LEU ILE GLY GLY GLY ILE SER GLU GLN GLY ASP ASN SEQRES 20 D 285 LEU ILE LYS TYR ILE GLU PRO LYS VAL ALA HIS TYR LEU SEQRES 21 D 285 PRO LYS ASP TYR VAL TYR ALA PRO ILE GLN THR THR LYS SEQRES 22 D 285 SER LYS ASN ASP ALA ALA LEU TYR GLY CYS LEU GLN HET BM3 A 301 30 HET BM3 B 301 30 HET BM3 C 301 30 HET BM3 D 301 30 HETNAM BM3 2-ACETAMIDO-2-DEOXY-ALPHA-D-MANNOPYRANOSE HETSYN BM3 N-ACETYL-ALPHA-D-MANNOSAMINE; 2-ACETAMIDO-2-DEOXY- HETSYN 2 BM3 ALPHA-D-MANNOSE; 2-ACETAMIDO-2-DEOXY-D-MANNOSE; 2- HETSYN 3 BM3 ACETAMIDO-2-DEOXY-MANNOSE; 2-(ACETYLAMINO)-2-DEOXY- HETSYN 4 BM3 ALPHA-D-MANNOPYRANOSE FORMUL 5 BM3 4(C8 H15 N O6) FORMUL 9 HOH *89(H2 O) HELIX 1 AA1 LEU A 39 GLN A 56 1 18 HELIX 2 AA2 ASN A 91 LYS A 97 1 7 HELIX 3 AA3 ASP A 108 HIS A 120 1 13 HELIX 4 AA4 GLU A 157 LEU A 161 5 5 HELIX 5 AA5 THR A 170 ALA A 176 1 7 HELIX 6 AA6 ALA A 176 GLY A 187 1 12 HELIX 7 AA7 HIS A 194 GLU A 204 1 11 HELIX 8 AA8 ASP A 206 ASP A 232 1 27 HELIX 9 AA9 GLY A 240 GLN A 245 5 6 HELIX 10 AB1 GLY A 246 ALA A 258 1 13 HELIX 11 AB2 HIS A 259 LEU A 261 5 3 HELIX 12 AB3 ASP A 278 CYS A 284 1 7 HELIX 13 AB4 LEU B 39 GLN B 56 1 18 HELIX 14 AB5 ASN B 91 LYS B 97 1 7 HELIX 15 AB6 ASP B 108 HIS B 120 1 13 HELIX 16 AB7 GLU B 157 LEU B 161 5 5 HELIX 17 AB8 THR B 170 ALA B 176 1 7 HELIX 18 AB9 ALA B 176 GLY B 187 1 12 HELIX 19 AC1 HIS B 194 GLU B 204 1 11 HELIX 20 AC2 ASP B 206 ASP B 232 1 27 HELIX 21 AC3 GLY B 240 GLN B 245 5 6 HELIX 22 AC4 GLY B 246 ALA B 258 1 13 HELIX 23 AC5 HIS B 259 LEU B 261 5 3 HELIX 24 AC6 ASP B 278 CYS B 284 1 7 HELIX 25 AC7 LEU C 39 GLN C 56 1 18 HELIX 26 AC8 ASN C 91 LYS C 97 1 7 HELIX 27 AC9 ASP C 108 HIS C 120 1 13 HELIX 28 AD1 GLU C 157 LEU C 161 5 5 HELIX 29 AD2 THR C 170 ALA C 176 1 7 HELIX 30 AD3 ALA C 176 GLY C 187 1 12 HELIX 31 AD4 HIS C 194 GLU C 204 1 11 HELIX 32 AD5 ASP C 206 ASP C 232 1 27 HELIX 33 AD6 GLY C 240 GLN C 245 5 6 HELIX 34 AD7 GLY C 246 ALA C 258 1 13 HELIX 35 AD8 HIS C 259 LEU C 261 5 3 HELIX 36 AD9 ASP C 278 CYS C 284 1 7 HELIX 37 AE1 LEU D 39 GLN D 56 1 18 HELIX 38 AE2 ASN D 91 LYS D 97 1 7 HELIX 39 AE3 ASP D 108 HIS D 120 1 13 HELIX 40 AE4 GLU D 157 LEU D 161 5 5 HELIX 41 AE5 THR D 170 ALA D 176 1 7 HELIX 42 AE6 ALA D 176 GLY D 187 1 12 HELIX 43 AE7 HIS D 194 GLU D 204 1 11 HELIX 44 AE8 ASP D 206 ASP D 232 1 27 HELIX 45 AE9 GLY D 240 GLN D 245 5 6 HELIX 46 AF1 GLY D 246 ALA D 258 1 13 HELIX 47 AF2 HIS D 259 LEU D 261 5 3 HELIX 48 AF3 ASP D 278 CYS D 284 1 7 SHEET 1 AA1 5 MET A 24 SER A 31 0 SHEET 2 AA1 5 GLN A 12 ILE A 18 -1 N SER A 15 O GLN A 28 SHEET 3 AA1 5 TYR A 3 ILE A 8 -1 N TYR A 3 O ILE A 18 SHEET 4 AA1 5 ILE A 62 SER A 66 1 O SER A 65 N ILE A 8 SHEET 5 AA1 5 VAL A 103 ASN A 107 1 O LYS A 104 N ILE A 62 SHEET 1 AA2 2 VAL A 69 VAL A 70 0 SHEET 2 AA2 2 ILE A 77 TYR A 79 -1 O TYR A 79 N VAL A 69 SHEET 1 AA3 4 ILE A 136 LYS A 141 0 SHEET 2 AA3 4 ILE A 127 LEU A 132 -1 N CYS A 129 O ALA A 139 SHEET 3 AA3 4 LEU A 235 GLY A 239 1 O LEU A 237 N PHE A 128 SHEET 4 AA3 4 ILE A 270 THR A 272 1 O GLN A 271 N ILE A 238 SHEET 1 AA4 5 MET B 24 SER B 31 0 SHEET 2 AA4 5 GLN B 12 ILE B 18 -1 N VAL B 17 O PHE B 25 SHEET 3 AA4 5 TYR B 3 ILE B 8 -1 N TYR B 3 O ILE B 18 SHEET 4 AA4 5 ILE B 62 SER B 66 1 O GLY B 63 N ILE B 4 SHEET 5 AA4 5 VAL B 103 ASN B 107 1 O LYS B 104 N ILE B 64 SHEET 1 AA5 2 VAL B 69 ASP B 71 0 SHEET 2 AA5 2 GLU B 76 TYR B 79 -1 O TYR B 79 N VAL B 69 SHEET 1 AA6 4 ILE B 136 LYS B 141 0 SHEET 2 AA6 4 ILE B 127 LEU B 132 -1 N ILE B 127 O LYS B 141 SHEET 3 AA6 4 LEU B 235 GLY B 239 1 O LEU B 237 N PHE B 128 SHEET 4 AA6 4 ILE B 270 THR B 272 1 O GLN B 271 N ILE B 238 SHEET 1 AA7 5 MET C 24 SER C 31 0 SHEET 2 AA7 5 GLN C 12 ILE C 18 -1 N VAL C 17 O PHE C 25 SHEET 3 AA7 5 TYR C 3 ILE C 8 -1 N TYR C 3 O ILE C 18 SHEET 4 AA7 5 ILE C 62 SER C 66 1 O GLY C 63 N ILE C 4 SHEET 5 AA7 5 VAL C 103 ASN C 107 1 O LYS C 104 N ILE C 64 SHEET 1 AA8 2 VAL C 69 VAL C 70 0 SHEET 2 AA8 2 ILE C 77 TYR C 79 -1 O TYR C 79 N VAL C 69 SHEET 1 AA9 4 ILE C 136 LYS C 141 0 SHEET 2 AA9 4 ILE C 127 LEU C 132 -1 N CYS C 129 O ALA C 139 SHEET 3 AA9 4 LEU C 235 GLY C 239 1 O LEU C 237 N PHE C 128 SHEET 4 AA9 4 ILE C 270 THR C 272 1 O GLN C 271 N ILE C 238 SHEET 1 AB1 5 MET D 24 SER D 31 0 SHEET 2 AB1 5 GLN D 12 ILE D 18 -1 N VAL D 17 O PHE D 25 SHEET 3 AB1 5 TYR D 3 ILE D 8 -1 N TYR D 3 O ILE D 18 SHEET 4 AB1 5 VAL D 61 SER D 66 1 O SER D 65 N ILE D 8 SHEET 5 AB1 5 VAL D 103 ASN D 107 1 O LYS D 104 N ILE D 62 SHEET 1 AB2 2 VAL D 69 VAL D 70 0 SHEET 2 AB2 2 ILE D 77 TYR D 79 -1 O TYR D 79 N VAL D 69 SHEET 1 AB3 4 ILE D 136 LYS D 141 0 SHEET 2 AB3 4 ILE D 127 LEU D 132 -1 N CYS D 129 O ALA D 139 SHEET 3 AB3 4 LEU D 235 GLY D 239 1 O LEU D 237 N PHE D 128 SHEET 4 AB3 4 ILE D 270 THR D 272 1 O GLN D 271 N ILE D 238 CRYST1 47.236 101.353 133.222 90.00 90.15 90.00 P 1 21 1 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.021170 0.000000 0.000055 0.00000 SCALE2 0.000000 0.009867 0.000000 0.00000 SCALE3 0.000000 0.000000 0.007506 0.00000